Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Schmid, M; Samonigg, H; Stöger, H; Auer, H; Sternthal, MH; Wilders-Truschnig, M; Reisinger, EC.
Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: case report.
Clin Infect Dis. 1995; 20(6):1543-1546
Doi: 10.1093/clinids/20.6.1543
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- Samonigg Hellmut
- Stöger Herbert
- Truschnig-Wilders Martini
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- We describe a 28-year-old female who presented with metastatic spread of a suspected occult tumor. The diagnosis of alveolar echinococcosis was established by needle biopsy of the liver and ELISA. The patient's clinical symptoms initially decreased after treatment with mebendazole, but the lesions progressed during the following 6 months. Albendazole was not available in Austria. Because the synthesis of interferon gamma (IFN-gamma) and IFN-alpha is markedly decreased in patients with echinococcosis, we treated our patient with IFN-gamma while continuing mebendazole therapy. This combination halted progression of the disease during the 12 months of follow-up.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Animals -
- Brain - pathology
- Drug Therapy, Combination -
- Echinococcosis, Hepatic - diagnosis
- Echinococcosis, Hepatic - drug therapy
- Echinococcosis, Hepatic - pathology
- Echinococcus - isolation & purification
- Female -
- Humans -
- Interferon-gamma - therapeutic use
- Liver - pathology
- Magnetic Resonance Imaging -
- Mebendazole - therapeutic use
- Tomography, X-Ray Computed -